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EDITORIAL COMMENT
Colloid Osmotic Pressure
An Under-Recognized Factor in the
Clinical Syndrome of Heart Failure*
Marvin A. Konstam, MD, FACC
Boston, Massachusetts
The clinical syndrome of left heart failure (HF) is often
simplistically characterized as dyspnea related to elevation of
pulmonary venous pressure. In fact, left HF may manifest as
one or a combination of several syndromes, including acute
dyspnea, chronic fatigue, functional incapacity, and systemic
fluid overload (associated with secondary right HF). Our
understanding of the linkage between hemodynamics and
these specific clinical manifestations of HF is incomplete. In
this issue of the Journal, Arque`s et al. (1) have shed light on
the importance of serum albumen and plasma oncotic
pressure as factors modulating or exacerbating the clinical
response to acute elevation of pulmonary artery wedge
pressure (PAWP).
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The relationship between resting hemodynamic measure-
ments and symptoms of HF is poor. Measurements at rest
are poorly predictive of hemodynamic derangement induced
during exercise. In the absence of pulmonary congestion,
dyspnea often relates to a shift from aerobic to anaerobic
metabolism, which occurs at low stress levels in patients
with HF, with a dampened cardiac output response to
exercise (2). Such a dampened response may be linked to
inadequate recruitment of contractility, heart rate, or pre-
load (3–5).
Likewise, the development of pulmonary congestion
correlates only roughly with pulmonary venous pressure
(approximated by PAWP). A number of factors influence
this relationship (6). Patients with chronic HF often man-
ifest little, if any, pulmonary congestion, despite sustained
elevation of PAWP. The rate of accumulation of alveolar
fluid, for any given hydrostatic pressure, is influenced by the
degree of permeability of the alveolar-capillary membrane.
Chronic pressure elevation in the pulmonary venous bed
may result in thickening of the pulmonary alveolar capillary
membrane, protecting the interstitium and air space from
transudation of vascular fluid (7–9). Conversely, factors that
increase the permeability of the alveolar-capillary membrane
will increase the rate of alveolar fluid accumulation at any
given hydrostatic gradient (10). Beyond membrane perme-
ability, the rate of accumulation of alveolar fluid is influ-
enced by the rate of pulmonary lymphatic drainage, which
tends to increase in response to increases in hydrostatic
pressure (11,12).
Arque`s et al. (1) bring to light the importance of plasma
oncotic pressure as an additional factor influencing the
likelihood and degree of pulmonary congestion at a given
pulmonary venous pressure. They observed hypoalbumin-
emia, with a resulting reduction in colloid osmotic pressure
(COP), among patients with acute dyspnea due to HF and
a normal left ventricular ejection fraction (LVEF), as
compared with: 1) patients with acute dyspnea, HF, and a
reduced LVEF; 2) those with dyspnea unrelated to HF; and
3) normal subjects. The PAWP tended to be higher in HF
patients with a reduced LVEF, resulting in similar COP-
PAWP gradients between HF patients with normal and a
reduced LVEF. They conclude that in a sizeable proportion
of patients presenting with acute dyspnea due to HF,
particularly those with a normal LVEF, hypoalbuminemia
represents a significant contributing factor.
Patients with HF and a normal LVEF, better character-
ized as those with the absence of LV cavity dilation (13),
generally are elderly patients with long-standing hyperten-
sion and concentric LV hypertrophy (14). They tend to be
exquisitely sensitive to dietary sodium and volume. In
addition to diminished ventricular and vascular compliance,
we can now add hypoalbuminemia as a physiologic contrib-
utor to the frequent occurrence of acute pulmonary edema
in this population.
Observed differences in serum albumen in patients with
normal versus reduced LVEF are unlikely to be due to
differences in LV function or ventricular volumes, per se. In
most cases, the authors attribute hypoalbuminemia to mal-
nutrition or sepsis. Advanced age is likely to predispose to
malnutrition, although the difference in average age be-
tween those with normal and reduced LVEF in the present
study was small. A more detailed exploration of the factors
responsible for hypoalbuminemia in this population is
warranted.
These findings highlight the differences between
community-based populations with HF and those patients
enrolled in clinical trials (15). In contrast to patients who
have participated in HF trials over the last two decades, the
population studied by Arque`s et al. (1) was older, with a
greater prevalence of comorbidities, including malnutrition
and sepsis. These factors are likely to contribute to morbid
events for patients in the “real world” far more than within
clinical trial populations, in which comorbidities represent
criteria for exclusion.
The management of patients with HF requires careful
attention to modifiable extra-cardiac contributing factors,
including physical conditioning, sodium intake, medication
compliance, and social support. Adequate nutrition is
known to be important in patients with advanced HF, in
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whom anorexia and circulating inflammatory cytokines
contribute to muscle wasting and increased disability. The
findings of Arque`s et al. (1) emphasize the complexity of the
linkage between cardiac dysfunction and the clinical mani-
festations of HF. In addition, they further emphasize the
importance of maintaining adequate nutrition as we strive to
improve clinical outcomes in our patients with HF.
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